Charlie's Holdings, Inc.

Charlie's Holdings, Inc. is a U.S.-based company in medicinal chemicals and botanical products, with a business model centered on products derived from cannabis or hemp-related botanical inputs. Based on the limited disclosure available, the company appears to operate in a highly regulated consumer health and wellness niche where product formulation, compliance, and brand positioning are central to its identity. Its filings emphasize broad operational and financial uncertainty, which is consistent with a small, regulation-sensitive company facing execution and market risks. Investors should view the business as one exposed to shifting legal frameworks, consumer demand trends, and the challenges of scaling a specialized botanical product portfolio.

−10,2 %

27,0 %

21,5 %

+146,2 %

1.41

0.53

— Charlie's Holdings, Inc.
%
Botanical and medicinal products100% Products derived from botanical or medicinal chemical inputs, likely sold in regulated wellness or therapeutic channels.

The company appears to sell into end markets that buy botanical or cannabis-related products for wellness, therapeutic,...

  • Regulated retail and wellness channelsprimary

    Retailers and channel partners buy botanical products for resale because they need compliant, differentiated offerings in a regulated category.

  • End consumersprimary

    Consumers buy the company's botanical products for wellness or therapeutic use, depending on product form and legal availability.

  • Distribution partnerssecondary

    Wholesalers and distributors buy products to extend market reach and access fragmented local channels.

The company is based in the United States, which is the key operating and regulatory environment for its business...

  • •United States is the primary operating base and likely core market
  • •No country-level revenue disclosure was available in the excerpts
  • •State-by-state regulation can materially affect product availability
  • •Geographic expansion depends on local licensing and legal status

The available disclosure suggests a strategy focused on operating within a regulated botanical product niche while...

01
Regulatory compliance and risk managementshort-term

The company operates in a category where legal status and product rules can change quickly and affect market access.

02
Distribution access and channel developmentmedium-term

A regulated botanical business depends on shelf access and partner relationships to reach customers efficiently.

The company explicitly notes that its results are subject to numerous risks and uncertainties, and that losses or...

high

Regulatory and legal uncertainty

The business depends on products that may be subject to changing federal, state, or local rules, which can affect whether products can be sold and how they must be marketed.

Scope
United States
Materiality
high
high

Operational losses and financial strain

The filing warns that losses or damages could materially affect financial results and the ability to conduct business as expected.

Materiality
high
medium

Product compliance and quality control

In regulated botanical markets, labeling, formulation, and claims must be tightly controlled to avoid enforcement or reputational damage.

Materiality
high
Revenue recognition for product sales
Inventory valuation and obsolescence
Impairment and going-concern judgments

Bespoke Extracts, Inc.

BSPK · Pharmaceutical Preparations

Charlotte's Web Holdings, Inc.

CWBHF · Agricultural Production-Crops

AIBOTICS, INC.

AIBT · Medicinal Chemicals & Botanical Products

Canton Strategic Holdings, Inc.

CNTN · Finance Services

TILT Holdings Inc.

TLLTF · Cigarettes

Australian Oilseeds Holdings Ltd

COOT · Fats & Oils

: 28/04/2026